GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity-Reference-Cited by-同舟云学术

GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity

Published:2014-04 Issue:1 Volume:323 Page:100-111
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Fiorentini Chiara,Bodei Serena,Bedussi Francesca,Fragni Martina,Bonini Sara Anna,Simeone Claudio,Zani Danilo,Berruti Alfredo,Missale Cristina,Memo Maurizio,Spano PierFranco,Sigala Sandra

Publisher

Elsevier BV

Subject

Cell Biology

Reference81 articles.

1. Cancer statistics;Jemal;CA: Cancer J. Clin.,2009

2. Pathologic basis of focal therapy for early-stage prostate cancer;Mouraviev;Nat. Rev. Urol.,2009

3. Molecular states underlying androgen receptor activation: a framework for therapeutics targeting androgen signaling in prostate cancer;Nelson;J. Clin. Oncol.,2012

4. Changing therapeutic paradigms in castrate-resistant prostate cancer;Zivi;Clin. Genitourin.Cancer,2010

5. Lineage dependency and lineage-survival oncogenes in human cancer;Garraway;Nat. Rev. Cancer,2006

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycoprotein non-metastatic melanoma protein B promotes tumor growth and is a biomarker for lymphangioleiomyomatosis;Endocrine-Related Cancer;2024-04-11

2. GPNMB Expression Associates with Inferior Prognosis in Patients with Small Cell Lung Cancer;Journal of Cancer;2024

3. Single cell transcriptional profiling of benign prostatic hyperplasia reveals a progenitor-like luminal epithelial cell state within an inflammatory microenvironment;2023-11-07

4. A novel molecular mechanism of vascular fibrosis in Takayasu arteritis: macrophage-derived GPNMB promoting adventitial fibroblast extracellular matrix production in the aorta;Translational Research;2023-05

5. Human Antibody V_H Domains Targeting GPNMB and VCAM-1 as Candidate Therapeutics for Cancers;Molecular Pharmaceutics;2023-04-17